Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Business As Usual For Menarini Despite Managing Siblings’ Fraud Sentence

Executive Summary

Siblings Lucia and Alberto Giovanni Aleotti, respectively president and vice-president of Italian pharmaceutical company Menarini, have been sentenced for tax fraud by a court in Florence. Lucia Aleotti has resigned from the board of Farmindustria, Italy’s industry association, but its president Massimo Scaccabarozzi declared his expectation that they would be cleared on appeal. The case is far from closed.

You may also be interested in...



Menarini Owners Acquitted Of Fraud

Lucia and Giovanni Aleotti have been cleared of fraud against the Italian health system, and will continue to lead the Florentine company transformed into a major multinational by their father.

Italian Industry Roadshow Hits The US To Talk Up Its Assets

The Italian pharmaceutical industry has been busy polishing up its profile abroad. Having taken part in government-sponsored "Invest in Italy" roadshows in Turkey and Japan in October and November 2015, a number of leading Italian companies recently headed to the US to explain why the Italian industry is worth investing in.

Which Way Now For Mid-Sized European Pharmas?

Compared with their top 20 European peers and with similarly sized companies in the US, many mid-sized European pharmas are struggling. IMS Health analyzes the predicament these companies find themselves in and outlines what they need to do to avoid being caught in an evolutionary backwater.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC097277

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel